Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules.

Ackermann C, Smits M, Woost R, Eberhard JM, Peine S, Kummer S, Marget M, Kuntzen T, Kwok WW, Lohse AW, Jacobs T, Boettler T, Schulze Zur Wiesch J.

Sci Rep. 2019 Jul 23;9(1):10624. doi: 10.1038/s41598-019-47024-8.

2.

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.

Scharpenseel H, Hanssen A, Loges S, Mohme M, Bernreuther C, Peine S, Lamszus K, Goy Y, Petersen C, Westphal M, Glatzel M, Riethdorf S, Pantel K, Wikman H.

Sci Rep. 2019 May 15;9(1):7406. doi: 10.1038/s41598-019-43678-6.

3.

Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours.

Ricklefs FL, Maire CL, Reimer R, Dührsen L, Kolbe K, Holz M, Schneider E, Rissiek A, Babayan A, Hille C, Pantel K, Krasemann S, Glatzel M, Heiland DH, Flitsch J, Martens T, Schmidt NO, Peine S, Breakefield XO, Lawler S, Chiocca EA, Fehse B, Giebel B, Görgens A, Westphal M, Lamszus K.

J Extracell Vesicles. 2019 Mar 21;8(1):1588555. doi: 10.1080/20013078.2019.1588555. eCollection 2019.

4.

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.

Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G.

J Clin Oncol. 2019 Jun 1;37(16):1412-1423. doi: 10.1200/JCO.18.01480. Epub 2019 Mar 15.

PMID:
30875280
5.

Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma.

Riethdorf S, Hildebrandt L, Heinzerling L, Heitzer E, Fischer N, Bergmann S, Mauermann O, Waldispühl-Geigl J, Coith C, Schön G, Peine S, Schuler G, Speicher MR, Moll I, Pantel K.

Clin Chem. 2019 Mar;65(3):462-472. doi: 10.1373/clinchem.2018.297028. Epub 2019 Jan 9.

PMID:
30626636
6.

Natural Killer Cell Education Is Associated With a Distinct Glycolytic Profile.

Pfeifer C, Highton AJ, Peine S, Sauter J, Schmidt AH, Bunders MJ, Altfeld M, Körner C.

Front Immunol. 2018 Dec 19;9:3020. doi: 10.3389/fimmu.2018.03020. eCollection 2018.

7.

Ethnic differences in fat and muscle mass and their implication for interpretation of bioelectrical impedance vector analysis.

Jensen B, Moritoyo T, Kaufer-Horwitz M, Peine S, Norman K, Maisch MJ, Matsumoto A, Masui Y, Velázquez-González A, Domínguez-García J, Fonz-Enríquez E, Salgado-Moctezuma SG, Bosy-Westphal A.

Appl Physiol Nutr Metab. 2019 Jun;44(6):619-626. doi: 10.1139/apnm-2018-0276. Epub 2018 Oct 24.

8.

Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status.

Landahl J, Bockmann JH, Scheurich C, Ackermann C, Matzat V, Heide J, Nuurei T, D'Antonio G, von Felden J, Sette A, Peine S, Lohse AW, Luetgehetmann M, Marget M, Sidney J, Schulze Zur Wiesch J.

J Infect Dis. 2019 Jan 29;219(4):568-577. doi: 10.1093/infdis/jiy549.

PMID:
30247653
9.

Further characterization of bovine hepacivirus: Antibody response, course of infection, and host tropism.

Baechlein C, Baron AL, Meyer D, Gorriz-Martin L, Pfankuche VM, Baumgärtner W, Polywka S, Peine S, Fischer N, Rehage J, Becher P.

Transbound Emerg Dis. 2019 Jan;66(1):195-206. doi: 10.1111/tbed.12999. Epub 2018 Sep 8.

PMID:
30126081
10.

Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors.

Kraef C, Schlein C, Hiller J, Westhölter D, Denzer U, Horvatits T, Peine S, Lohse AW, Lütgehetmann M, Polywka S, Pischke S.

J Clin Virol. 2018 Aug;105:26-30. doi: 10.1016/j.jcv.2018.05.013. Epub 2018 May 29.

PMID:
29860111
11.

Lack of evidence for human serum albumin as major source of HEV infections.

Horvatits T, Westhölter D, Peine S, Schulze Zur Wiesch J, Lohse AW, Lütgehetmann M, Pischke S.

Transfus Med. 2018 Dec;28(6):470-471. doi: 10.1111/tme.12536. Epub 2018 Apr 30. No abstract available.

PMID:
29707836
12.

HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients.

Westhölter D, Hiller J, Denzer U, Polywka S, Ayuk F, Rybczynski M, Horvatits T, Gundlach S, Blöcker J, Schulze Zur Wiesch J, Fischer N, Addo MM, Peine S, Göke B, Lohse AW, Lütgehetmann M, Pischke S.

J Hepatol. 2018 Jul;69(1):36-42. doi: 10.1016/j.jhep.2018.02.031. Epub 2018 Mar 15.

PMID:
29551705
13.

Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism.

Jiménez-Alcázar M, Limacher A, Panda R, Méan M, Bitterling J, Peine S, Renné T, Beer JH, Aujesky D, Lämmle B, Fuchs TA.

PLoS One. 2018 Feb 23;13(2):e0191150. doi: 10.1371/journal.pone.0191150. eCollection 2018.

14.

Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.

Mohme M, Schliffke S, Maire CL, Rünger A, Glau L, Mende KC, Matschke J, Gehbauer C, Akyüz N, Zapf S, Holz M, Schaper M, Martens T, Schmidt NO, Peine S, Westphal M, Binder M, Tolosa E, Lamszus K.

Clin Cancer Res. 2018 Sep 1;24(17):4187-4200. doi: 10.1158/1078-0432.CCR-17-2617. Epub 2018 Feb 14.

PMID:
29444930
15.

AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy.

Oh SJ, Mandel P, Chun FKH, Tennstedt P, Peine S, Hohenhorst JL, Hiller J, Graefen M, Tilki D, Steuber T.

Front Surg. 2017 Dec 18;4:75. doi: 10.3389/fsurg.2017.00075. eCollection 2017.

16.

The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.

Rink M, Engel O, Gakis G, Fritsche HM, Vetterlein MW, Soave A, Peine S, Aziz A, Dahlem R, Stenzl A, Burger M, Shariat SF, Fisch M, Gild P.

Urol Oncol. 2017 Dec;35(12):671.e17-671.e23. doi: 10.1016/j.urolonc.2017.08.007. Epub 2017 Sep 8.

PMID:
28889922
17.

Systematic Comparison of IgM and IgG ABO Antibody Titers by Using Tube and Gel Card Techniques and its Relevance for ABO-Incompatible Kidney Transplantation.

Khalili I, Koch M, Thaiss F, Plaetke R, Bruegger J, Peine S.

Clin Lab. 2017 Sep 1;63(9):1393-1401. doi: 10.7754/Clin.Lab.2017.170229.

PMID:
28879711
18.

Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients.

Kuske A, Gorges TM, Tennstedt P, Tiebel AK, Pompe R, Preißer F, Prues S, Mazel M, Markou A, Lianidou E, Peine S, Alix-Panabières C, Riethdorf S, Beyer B, Schlomm T, Pantel K.

Sci Rep. 2016 Dec 21;6:39736. doi: 10.1038/srep39736.

19.

Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans.

Soltau I, Mudersbach E, Geissen M, Schwedhelm E, Winkler MS, Geffken M, Peine S, Schoen G, Debus ES, Larena-Avellaneda A, Daum G.

PLoS One. 2016 Dec 14;11(12):e0168302. doi: 10.1371/journal.pone.0168302. eCollection 2016.

20.

Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells.

Gorges TM, Kuske A, Röck K, Mauermann O, Müller V, Peine S, Verpoort K, Novosadova V, Kubista M, Riethdorf S, Pantel K.

Clin Chem. 2016 Nov;62(11):1504-1515. Epub 2016 Sep 14.

21.

Heterogeneous PSMA expression on circulating tumor cells: a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer.

Gorges TM, Riethdorf S, von Ahsen O, Nastał Y P, Röck K, Boede M, Peine S, Kuske A, Schmid E, Kneip C, König F, Rudolph M, Pantel K.

Oncotarget. 2016 Jun 7;7(23):34930-41. doi: 10.18632/oncotarget.9004.

22.

Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.

Rink M, Soave A, Dahlem R, Aziz A, Al-Sayed F, Peine S, Engel O, Kluth LA, Stenzl A, Burger M, Shariat SF, Fisch M, Fritsche HM, Gakis G.

Clin Genitourin Cancer. 2016 Feb;14(1):96-104. doi: 10.1016/j.clgc.2015.10.003. Epub 2015 Oct 20.

PMID:
26506908
23.

Decreased serum concentrations of sphingosine-1-phosphate in sepsis.

Winkler MS, Nierhaus A, Holzmann M, Mudersbach E, Bauer A, Robbe L, Zahrte C, Geffken M, Peine S, Schwedhelm E, Daum G, Kluge S, Zoellner C.

Crit Care. 2015 Oct 26;19:372. doi: 10.1186/s13054-015-1089-0.

24.

Role of the Fyn -93A>G polymorphism (rs706895) in acute rejection after liver transplantation.

Thude H, Kramer K, Peine S, Sterneck M, Nashan B, Koch M.

Hum Immunol. 2015 Sep;76(9):657-62. doi: 10.1016/j.humimm.2015.09.013. Epub 2015 Sep 25.

PMID:
26407913
25.

De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation.

Koch M, Wiech T, Marget M, Peine S, Thude H, Achilles EG, Fischer L, Lehnhardt A, Thaiss F, Nashan B.

Clin Transplant. 2015 Nov;29(11):1021-8. doi: 10.1111/ctr.12624. Epub 2015 Oct 5.

PMID:
26333844
26.

Syndrome hémolytique et urémique.

Schmidtko J, Rohrer F, Peine S.

Rev Med Suisse. 2015 Feb 25;11(463):523. French. No abstract available.

PMID:
25898460
27.

The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.

Engel O, Soave A, Peine S, Kluth LA, Schmid M, Shariat SF, Dahlem R, Fisch M, Rink M.

World J Urol. 2015 Nov;33(11):1769-76. doi: 10.1007/s00345-015-1531-6. Epub 2015 Mar 18.

PMID:
25782867
28.

Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation.

Grabhorn E, Binder TM, Obrecht D, Brinkert F, Lehnhardt A, Herden U, Peine S, Nashan B, Ganschow R, Briem-Richter A.

Transplantation. 2015 Sep;99(9):1876-81. doi: 10.1097/TP.0000000000000638.

PMID:
25706279
29.

Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies.

Jiménez-Alcázar M, Napirei M, Panda R, Köhler EC, Kremer Hovinga JA, Mannherz HG, Peine S, Renné T, Lämmle B, Fuchs TA.

J Thromb Haemost. 2015 May;13(5):732-42. doi: 10.1111/jth.12796. Epub 2015 Apr 13.

30.

Lack of association between CD40 polymorphisms and acute rejection in German liver transplant recipients.

Thude H, Kramer K, Koch M, Peine S, Sterneck M, Nashan B.

Hum Immunol. 2014 Nov;75(11):1123-7. doi: 10.1016/j.humimm.2014.09.024. Epub 2014 Oct 11.

PMID:
25305459
31.

Polymorphism in NFKBIA gene is associated with recurrent acute rejections in liver transplant recipients.

Kramer K, Thye T, Treszl A, Peine S, Koch M, Sterneck M, Nashan B, Thude H.

Tissue Antigens. 2014 Oct;84(4):370-7. doi: 10.1111/tan.12411. Epub 2014 Aug 11.

PMID:
25112903
32.

Hematogenous dissemination of glioblastoma multiforme.

Müller C, Holtschmidt J, Auer M, Heitzer E, Lamszus K, Schulte A, Matschke J, Langer-Freitag S, Gasch C, Stoupiec M, Mauermann O, Peine S, Glatzel M, Speicher MR, Geigl JB, Westphal M, Pantel K, Riethdorf S.

Sci Transl Med. 2014 Jul 30;6(247):247ra101. doi: 10.1126/scitranslmed.3009095.

33.

In reply to 'Beneficial effect of eculizumab on thrombotic microangiopathies: another point of view'.

Schmidtko J, Peine S.

Am J Kidney Dis. 2014 Jan;63(1):167. doi: 10.1053/j.ajkd.2013.10.053. No abstract available.

PMID:
24360228
34.

Medical mission to dominican republic: one dermatology group?s experiences.

Ahmed A, Peine S.

J Spec Oper Med. 2013 Summer;13(2):69-74. Review.

PMID:
23817882
35.

Lack of association between CTLA-4 and PDCD1 polymorphisms and acute rejection in German liver transplant recipients.

Thude H, Schipler AD, Treszl A, Peine S, Koch M, Sterneck M, Nashan B.

Hum Immunol. 2013 Aug;74(8):1041-5. doi: 10.1016/j.humimm.2013.04.021. Epub 2013 Apr 27.

PMID:
23628397
36.

Transcapsular arterial neovascularization of liver transplants increases the risk of intraoperative bleeding during retransplantation.

Herrmann J, Herden U, Ganschow R, Petersen KU, Schmid F, Derlin T, Koops A, Peine S, Sterneck M, Fischer L, Helmke K.

Transpl Int. 2013 Apr;26(4):419-27. doi: 10.1111/tri.12062. Epub 2013 Jan 25.

37.

Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.

Schmidtko J, Peine S, El-Housseini Y, Pascual M, Meier P.

Am J Kidney Dis. 2013 Feb;61(2):289-99. doi: 10.1053/j.ajkd.2012.07.028. Epub 2012 Nov 7. Review.

PMID:
23141475
38.

Paroxysmal nocturnal hemoglobinuria turning Coombs-positive.

Röth A, Peine S, Dührsen U.

Int J Hematol. 2010 Mar;91(2):159-60. doi: 10.1007/s12185-010-0493-0. Epub 2010 Feb 9. No abstract available.

PMID:
20140782
39.

What is your diagnosis? Cutaneous leishmaniasis.

Peine SD, Bryan MG.

Cutis. 2004 Nov;74(5):284, 287-8. No abstract available.

PMID:
15605963
40.

[Platelet retention test Homburg (RTH) and drug monitoring of platelet adhesive properties of von Willebrand factor].

Wieding JU, Köstering H, Peine S, Wermes C, Mestres P, Wenzel E.

Hamostaseologie. 2004 Aug;24(3):217-20. Review. German.

PMID:
15314709
41.

Pain management and prescription monitoring.

Joranson DE, Carrow GM, Ryan KM, Schaefer L, Gilson AM, Good P, Eadie J, Peine S, Dahl JL.

J Pain Symptom Manage. 2002 Mar;23(3):231-8. Review.

PMID:
11888721

Supplemental Content

Support Center